pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Apr 28·1 min read
save

Health system CEOs face Congress on affordability, hearing shifts blame to opposing party's policies

Apr 28, 2026·read at STAT ↗RegulatoryNeutral

The House Ways and Means Committee held a hearing to examine the drivers of rising health‑care costs, calling CEOs of several large health systems to testify.

CEOs from HCA Healthcare, CommonSpirit Health, New York‑Presbyterian and ECU Health appeared relieved early on as some committee members seemed supportive.

The discussion quickly turned political, with members largely attributing high prices to policies of the opposing party rather than the health systems themselves.

The hearing follows a similar session three months earlier in which top health insurers shifted blame onto hospitals and drugmakers.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Health system CEOs get off easy at Congressional hearing on affordability”

read at STAT ↗
464 words · retrieved Apr 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Protara Therapeutics, Inc.7HCA Healthcare, Inc.2RISING2Ultragenyx Pharmaceutical Inc.
topics
OncologyRare Disease

related stories

  • Oct 13Analysts eye RevMed’s pancreatic cancer launch, Merck’s data blitz for Q3 earningsBioSpace
  • Oct 75 biggest venture capital raises of Q3 2026BioSpace
  • Oct 5Swiss CDMOs and CROs ride a new wave of growth amid surge in global demandBioSpace
  • Sep 23China’s surging biotech sector represents both competition and lifeline for the USBioSpace
  • Sep 14Electra aims for $342M IPO to power inflammatory drug’s push through phase 3Fierce Biotech